F323-0530 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-2-[3,3-dimethyl-2-oxo-5-(piperidine-1-sulfonyl)-2,3-dihydro-1H-indol-1-yl]acetamide

F323-0530 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-2-[3,3-dimethyl-2-oxo-5-(piperidine-1-sulfonyl)-2,3-dihydro-1H-indol-1-yl]acetamide
F323-0530 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-2-[3,3-dimethyl-2-oxo-5-(piperidine-1-sulfonyl)-2,3-dihydro-1H-indol-1-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F323-0530
N-(2H-1,3-benzodioxol-5-yl)-2-[3,3-dimethyl-2-oxo-5-(piperidine-1-sulfonyl)-2,3-dihydro-1H-indol-1-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F323-0530

Molecular Formula

C24H27N3O6S (C24 H27 N3 O6 S)

Compound Name

N-(2H-1,3-benzodioxol-5-yl)-2-[3,3-dimethyl-2-oxo-5-(piperidine-1-sulfonyl)-2,3-dihydro-1H-indol-1-yl]acetamide

IUPAC name

N-(2H-13-benzodioxol-5-yl)-2-[33-dimethyl-2-oxo-5-(piperidine-1-sulfonyl)-23-dihydro-1H-indol-1-yl]acetamide

SMILES

CC(C)(c(cc(cc1)S(N2CCCCC2)(=O)=O)c1N1CC(Nc(cc2)cc3c2OCO3)=O)C1=O

InChI

InChI=1S/C24H27N3O6S/c1-24(2)18-13-17(34(30,31)26-10-4-3-5-11-26)7-8-19(18)27(23(24)29)14-22(28)25-16-6-9-20-21(12-16)33-15-32-20/h6-9,12-13H,3-5,10-11,14-15H2,1-2H3,(H,25,28)

InChI Key

MGHZOUXAABJSPL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27116096

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

485.56

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.435

Distribution Coefficient, logD

3.435

Water Solubility, LogSw

-3.89

Polar Surface Area

87.683

Acid Dissociation Constant (pKa)

11.21

Base Dissociation Constant (pKb)

3.05

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.70

F323-0530 in Drug Discovery

Included in Screening Libraries

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Targeted Diversity Library (40567 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with F323-0530 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F323-0530?
Check Price and Availability of F323-0530, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F323-0530 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F323-0530
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F323-0530
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F323-0530 available by request